Important New Mylotarg Information
Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg.
Press release 
Acute Myeloid Leukemia (AML) Fact Sheet
Prescribing Information
Dear Healthcare Professional Letter
– Conference call for Analysts and Investors
We still have your Wyeth content:
- Where we have moved things
- Wyeth Prescription Products
- Wyeth Over-the-Counter Products
- Wyeth Patient Assistance Program
- Wyeth Worldwide sites
- Wyeth Health Care Professionals
- Wyeth Animal Health Professionals
NYSE: PFE
15.33
0.33
July 29, 2010 — Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference
July 23, 2010 — EISAI INC. AND PFIZER INC ANNOUNCE U.S. FDA APPROVAL FOR NEW HIGHER-DOSE ARICEPT® (DONEPEZIL HCL) 23 MG TABLET FOR THE TREATMENT OF MODERATE-TO-SEVERE ALZHEIMER’S DISEASE
July 22, 2010 — Pfizer to Offer Free Public Access to Mental Health Assessment Tools to Improve Diagnosis and Patient Care
- Contact Us
- Investors
- Sitemap
- Careers
- Business to Business
- Terms of Use
- Global Network
- Privacy Policy
Copyright © 2002–2010 Pfizer Inc. All rights reserved. This information is intended only for residents of the United States. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries. Pfizer Inc is a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.
